Background: Dietary supplements of Carica papaya Linn fermented with yeast using a biotechnological process have well recognized positive effects on immunological, hematological, inflammatory, and oxidative stress parameters, utilized as biomarkers of chronic and degenerative diseases. Although many natural products fermented with lactic acid bacteria (LAB) have shown beneficial effects on the immune system and on antioxidant defenses, formulations of papaya fermented with LAB have not yet been studied.
INTRODUCTION
Dietary supplementation containing live bacteria promotes health effects and reduces the risk of various diseases [1] not only by affecting the intestinal microflora but also by modulating the immunological parameters and the intestinal permeability as well as by producing bioactive metabolites [2] . Lactic Acid Bacteria (LAB) are gram-positive, non-spore forming, anaerobic bacteria present in a variety of habitats including the human and animal intestinal tract, material of plant origin, and sewage; LAB are frequently used as probiotics, either alone or in combination of different strains for the fermentation of food products [3] .
By considering the many types of potential fermentation substrates and conditions, LAB strains may be considered as functional performance bacteria and are expected to be used in the development of new food-based probiotics in the future. Even if many LAB are currently used in the dairy industry to produce cheese, yogurt, and other fermented milk products [4] , increased use has been observed among the non-dairy probiotic foods, such as vegetables and fruit juices due to the high amounts of bioactive molecules produced by the proteolytic activity of LAB [5] . Lactic acid fermentation enhances the micronutrient profile of foods: fermented dairy products consistently reveal an increased level of folic acid which is critical for babies' health as well as pyroxidine, B vitamins, riboflavin, and biotin depending on the strains of bacteria present [6] . Vegetables, fruits, legumes, and grains subjected to lactic acid fermentation have an improved macro and micronutrient profiles and bioavailability, and are specifically characterized by increased levels of vitamin C, vitamin A, and lysine with its antiviral effects and methionine [7] .
As probiotics, LAB are important for enhancing the immunity responses, the maintenance of the intestinal microbial balance and the prevention of gastrointestinal infection by influencing the biochemical, physiological, and antimicrobial activities or by changing the composition of the intestinal microflora [8] . Numerous cell types are involved in these responses, including epithelial cells, dendritic cells (DC), monocytes/macrophages, B cells, T cells, and NK cells [9] . Several strains of LAB (mostly Lactobacillus, Streptococcus, and Bifidobacterium strains) enhance both the innate and adaptive immune response through induction of dendritic cell maturation and further stimulating the lymphocytes to release pro-inflammatory cytokines, including tumor necrosis factor alpha (TNFα), interferon-gamma (IFNγ), several interleukins (IL-1β, -6, -12), and nitric oxide (NO) [10, 11] . LAB fermentation is largely used not only to enhance the immune-modulatory features of several foods and botanicals [12] , but also to increase the antioxidant features thanks to the degradation of polyphenols in the more bioavailable phenolic acids [13] .
The balance between the production of ROS and antioxidants is essential in a biological system to prevent adverse effects of oxidative stress [14] . Antioxidant agents are able to modulate the concentration of ROS and RNS at a cellular level may, and are therefore helpful in preventing Alzheimer disease (AD) and several other diseases, especially ones related to aging such as diabetes, cancer, cardiovascular and neurological diseases, and cataracts and glaucoma [15] [16] . Marchetti and Abbracchio in 2005 postulated that "novel therapeutic approaches must rely on potentiation of endogenous anti-inflammatory pathways and on a combination of treatment involving immune modulation and anti-inflammatory therapies" [17] .
Fermented papaya preparation, produced by fermentation of Carica papaya Linn by using yeasts, is a well-known food supplement that exhibits anti-inflammatory, antioxidant, and immunostimulatory action, properties that may be helpful against age-related diseases [10, 16] .
Since it has been shown that fermented foods with LAB can be beneficial to the immune system [18] and ameliorate the antioxidant activity [19] but formulations of papaya fermented with probiotics have not yet been studied, the purposes of this study were the following: 1) to compare the immunomodulatory activity linked to the type of papaya fermentation (yeast vs LAB) through the analysis of the effects on the transcriptional activation of iNOS and TNFα in macrophages previously treated with IFN-γ, a well-known inducer of the initial steps of immune response and 2) to evaluate whether the type of papaya fermentation differently modulates oxidative stress both in cell free system and in a model of embryonic brain cells.
MATERIALS AND METHODS

Materials.
The papaya fermented formulation used in this study is constituted by a puree of Papaya (Carica Papaya Linn) fermented through a process of lactic fermentation using a combination of three lactic acid bacteria strains (Streptococcus Thermophilus, Lactobacillus Acidophilus, Bifidobacterium A. Subsp. Lactis), named FPPB. Data where compared with a commercially available formulation of yeasts-fermented papaya (FPPA), known as Immunage, prepared at the Osato Research Institute, Gifu, Japan.
RAW264.7 and DMEM were obtained from the American Tissue Colture Collection. Fetal Bovine Serum (FBS), RPMI, horse serum, Penicillin/Streptomycin (P/S) solution, glutamine, Carboxy-H 2 DCFDA, SuperScript III reverse transcriptase, random hexamers, dNTPs, RNase Out, mouse-IFNγ, and LDH cytotoxicity assay kit were purchased from Thermo Fischer (Carlsbad, CA, USA). RNeasy Mini Kit and Qiashredder were obtained from Qiagen (Hilden, Germany). PerfeCta SYBR Green SuperMix with ROX kit were from Quanta Biosciences (Gaithersburg, MD, US). Primers for RT-PCR were purchased from IDT (Coralville, IA, USA). PC12 cells, PBS tabs, collagen type IV, Trypsin-EDTA, Horseradish Peroxidase (HRP), Trolox (6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid), phenethyl isothiocyanate (PEITC), benzyl isothiocyanate (BITC), 2,2′-Azobis(2-methylpropionamidine), dihydrochloride (AAPH), and fluorescein sodium salt were purchased from Sigma Aldrich. ECL Western Lightning ULTRA Reagents was purchased from Perkin Elmer. All the other chemicals and solvents were of the highest analytical grade. All solutions were prepared with pyrogen-free reagent-grade water using a Milli-Q system (Millipore, Milan, Italy).
Methods.
Cell culture RAW 264.7 (mouse leukemic monocyte macrophage cell line) were grown in DMEM containing 10% FBS and P / S; for experiments we used the cells from passage 3 to 7, in order to avoid possible changes of cellular phenotype. RAW 264.7 cells were incubated with solutions of FPP (3-6-9 mg / ml) in the presence or absence of IFNγ 100U / ml for 24 hours.
Rat adrenal pheochromocytoma PC12 cells were plated in collagen type IV coated flasks and grown in RPMI containing 10% horse serum, 5% FBS, 2mM Glutamine, and P/S. Cells were incubated with solutions of FPP (3 and 6 mg / ml) in a complete medium for 24 hours and the intracellular ROS levels were detected with the oxidant probe H 2 DCFDA in the presence or absence of a 30 minutes exposure to 100 µM hydrogen peroxide (H 2 O 2 ), as described in [20] . Trolox treatment was used as positive control (500 µM for 24 hours).
Cell proliferation assay.
2.5×10
5 cells in the logarithmic growth phase were harvested and seeded in 24 wells overnight.
The treatments were added and the cells were further incubated for various periods of time (2-4-7 days). At the end of incubation, cell number and viability was determined with Countess automated cell counter (Thermo Fischer) utilizing Trypan Blue as a dye. Growth kinetic curve was drawn according to the number of viable cells vs incubation time.
RNA extraction.
RAW 264.7 (5.0×10 5 /well) were incubated with solutions of FPP (3 mg / ml) in the presence or absence of IFN-γ 100U / ml for 24 hours. Total RNA was extracted using a commercially available kit (RNeasy Mini-Kit, Qiagen, Hilden, Germany) as it is reported in [21] .
Real-Time PCR. 500 ng of total RNA were reverse transcribed in a volume of 25 µl using 250 units of SuperScript III reverse transcriptase and 50 ng of random hexamers as it is reported in Caliceti [21] . Reaction conditions were as suggested by the manufacturer. 2 µl of the cDNA mixture were used for Real-Time PCR experiments to measure the amount of iNOS and TNFα transcripts (ref Ct formula using RPL13A as reference gene [21] .
Determination of oxygen radical scavenging capacity (ORAC).
The antioxidant activity of the formulations was estimated by oxygen radical absorbance capacity (ORAC) assay, using fluorescein as the fluorescent probe [22] . Briefly, 50 µL of blank, Trolox standard solutions (10-50 µM), and several dilutions of the preparations (FPPA and FPPB: range from 9 mg/ml to 500 µg/ml) were transferred to triplicate wells in a black 96-wells plate. After incubation at 37 °C for 10 min, 50 µL of fluorescein (78 nM) was added to each well and cells were incubated at 37 °C for another 20 min. 
Intracellular ROS measurement.
Intracellular levels of ROS were measured as previously described [20] . Briefly, PC12 cells (8×10 4 /ml) were seeded in a black 96 wells plate and treated with solutions of FPP, FPPA and FPPB at a concentration of 3 and 6 mg / ml for 24 hours. Cells were washed in PBS and incubated with 5 µM 2',7'-dichlorofluorescin-diacetate (DCFH 2 -DA) for 20 min at 37˚C. The fluorescence of oxidized probes was measured on a multiwell plate reader (Varioskan, Thermo Scientific) in the presence or absence of 30 min treatment with 100 µM of hydrogen peroxide (H 2 O 2 ). Trolox treatment (500 µM for 24 hours) was used as positive control. Excitation wavelength was 485 nm and emission wavelength was 535 nm.
Statistical analysis
Results are expressed as means of three independent experiments with SEM. The statistical probability was determined by two-tailed Student's t test and considered to be significantly different at the level of p < 0.05.
RESULTS AND DISCUSSION
Safety of FPP formulations using an in vitro assay. When used for the treatment of RAW 264.7 and PC12 cell lines at different concentrations ranging from 3 to 9 mg/ml for 2 and 4 days (Figures 1 and 2 ) all the formulations didn't reduce the cell proliferation, as demonstrated by the growth curves and the number of dead cells, which was less than 15%, similar to control group using only the vehicle (Figures 1 and 2) . At day 7, cells treated with (both RAW 264.7 and PC12) formulations at concentration 9.0 mg / ml were almost all dead while those treated with the formulations at lower concentrations (3 and 6 mg/ml) were in over-confluence (data not shown). and these two studies is probably due to the difference in the experimental procedures. Several studies assessed the effect of FPPA on nitric oxide production and TNFα secretion in RAW 264.7 macrophages indicating that it exerts immunomodulatory activity [23] . NO, as a freeradical gasomediator, is synthesized by inducible nitric oxide synthase (iNOS) and mediates diverse functions, including immunoresponses, inhibition of platelet aggregation and of extracellular matrix production [25] to destroy invading pathogenic microbes as part of the body's defense mechanism against disease [26] .
FPPA was found to up-regulate the IFNγ-induced NO production in a dose-dependent manner [24] . The effect of FPPA on NO production was not due to changes in the activity of iNOS but to the increase of iNOS mRNA. Interestingly, the ability of FPPA to augment IFNγ-induced iNOS mRNA expression was independent of any changes on the mRNA stability [24] .
FPPA alone did not affect NO production but also augmented the mRNA expression of TNFα and interleukin-l β in the presence of IFNγ, which in turn determines the induction of iNOS gene, thereby suggesting that FPPA may not only be directly involved in the expression of iNOS but also has potential synergistic interaction with IFNγ to induce NO synthesis [24] . treated with 100 U / ml of Interferon γ (IFNγ) for 24 hours. Total RNA was extracted and qRT-PCR analysis of (A) iNOS and (B) TNFα gene expression was performed. RAW 264.7 were treated with 100 U / ml of Interferon γ (IFNγ) for 24 hours in the presence of FPPA (3 mg/ml) and FPPB (3 mg/ml). Total RNA was extracted and qRT-PCR analysis of (C) iNOS and (D) TNFα gene expression was performed.
Relative changes in mRNA expression levels were calculated according to the 2-ΔΔCt method using RPL13A as reference gene. Results are expressed as mean ± SEM of three independent experiments. ** P<0.01, ***P<0.001 significantly different from the control; °°° P<0.001 significantly different from FPPA.
ROS scavenging activity and antioxidant effect of FPP formulations in PC12 cells.
Earlier studies have indicated that FPPA has antioxidant activity in vitro and in vivo via inhibition of lipid peroxidation and protection of human T-lymphocytes challenged with ferric nitrilotriacetate and hydrogen peroxide (Fe-NTA/H 2 O 2 ) that induce single and double strand breaks [27] . Electron paramagnetic resonance (EPR) spin trapping studies demonstrated that antioxidant properties of FPPA are related to both hydroxyl scavenging as well as iron chelating properties [27] [28] . It has been discovered that FPPA scavenges superoxide anion radicals generated by the hypoxanthine-xanthine oxidase system [27] .
In the present study, preliminarily the direct "scavenger activity" of the preparations was determined through ORAC FL assay, and intracellular ROS measurements were performed on pheochromocytoma PC12 cells exposed to an oxidative stress.
Data in Table 1 revealed that FPPB acts as a mild scavenger of ROS while having higher activity in comparison to FPPA which revealed a low effect (Table 1) . This was probably due to LAB fermentation which has been discovered to enhance the overall functional properties of foods beyond original nutritional values, primarily due to the biotransformation of phenolics [29] . In contrast with Amer et al. [30] , our data revealed a clear scavenging effect of FPPA in a cell-free system measured by one unconventional method, specifically by using dichloro-dihydro fluorescein (DCF) as a probe.
The in vitro antioxidant activity of the formulations was then evaluated in rat pheochromocytoma PC12 cells, a mixture of neuroblastic and eosinophilic cells able to differentiate into neurons [31] , which was used as a model of brain, the organ most affected by hypoxia and consequent oxidative stress. In the presence of 100 µM of H 2 O 2 for 30 min, mimicking intracellular oxidative stress, the formulations FPPA and FPPB at 3 and 6 mg/ml did not significantly affect ROS level (Figure 4 ) in PC12 cells, even if there is a tendency to decrease. Aruoma et al. showed that FPPA treatment prior to incubation with H 2 O 2 protects from oxidative DNA damage PC12 cells, significantly increasing viability and sustaining morphology and shape of cells, at least in part through the reduction of the MAPK p38 phosphorylation [32] . Similarly, Zhang et al. (2006) found that supplementation of FPPA in an Alzheimer's disease cell model represented by SH-SY5Y cells (APP cells) stably overexpressing a β-amyloid precursor protein Swedish mutated (APPsw) was able to decrease the production of hydroxyl radicals and superoxide anion [33] . Thus, our results may be due to the different cellular model and/or the different method utilized to assess the antioxidant activity. In a nutrigenomics study related to FPPA efficacy, Marotta et al. [34] found that the genes for antioxidant enzymes catalase, superoxide dismutase (SOD), and glutathione peroxidase, as well as the gene for the DNA repair enzyme human 8-oxoguanine glycosylase (hOGG1), were up-regulated by FPPA. As a result, further studies (either in animals or in humans) are needed to corroborate our preliminary data of the beneficial effects of the LAB-fermented preparations in oxidative stress. with FPPA (3, 6 mg/ml), FPPB (3, 6 mg/ml) or Trolox (500 µM) and then exposed to oxidative stress generated by 100 µM H2O2 for 30 min. ROS levels were measured by means of H2DCF-DA assay as described in Materials and Methods Section. Results are expressed as means ± SEM of three independent experiments. ** P<0.01 significantly different from the control (V). The European vision of the Joint Programming Initiative (JPI) "A healthy diet for a healthy life" is that by 2030 all citizens will have the motivation, ability, and opportunity to consume a healthy diet from a variety of foods (included functional foods and supplements), to have healthy levels of physical activity, and significant decrease of diet-related diseases. In this context, new findings reported in this study indicate that a Carica papaya preparation fermented with LAB can improve the immune function as well as the antioxidant defenses. This report supports the context that a supplementation of nutraceuticals and/or functional food exhibiting antioxidant and immunostimulatory effects may have beneficial prophylactic properties in the management of chronic diseases linked to aging and expands their uses as a multifunctional agent in preventive medicine. This study was conducted in vitro, and further in vivo studies are needed to confirm these findings in animals and humans. The chemical structure and effective dosage of functional candidate compounds are different in vivo from that in vitro. Recently it has been demonstrated that yeast fermented papaya preparation contains single phenolic acids and many kinds of lowmolecular-weight substances but no polymerized structures [35] . These low-molecular-weight substances behave similar to polymerized polyphenols in vivo that are broken down and absorbed in the intestines by intestinal microflora, suggesting that the original structures of polyphenols do not necessarily mediate their functions in vivo.
CONCLUSION
In a recent paper by Yuhzo Fujita et al. [35] , clinical effects of yeast fermented papaya administration (3 and 9 g/day) in tube-fed older patients were observed, demonstrating that lowmolecular-weight phenolic acids are bioactive. This study is in accordance with several studies that have demonstrated that aerobic fermentation enhances polyphenol bioactivity [36] [37] [38] . Yuhzo Fujita et al. also showed that yeast-fermented papaya supplementation affected the composition of colon microflora, reducing the abundance of Firmicutes possibly through the decrease of bile acids. Consequently, development of fermentation biotechnology may introduce useful low-molecular-weight compounds with improved absorption and human health benefits.
In order to explain the increase of the immunostimulant and antioxidant activities due to lactic acid fermentation, a metabolomic study will be conducted to characterize the metabolites in Carica papaya preparation after LAB fermentation.
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